Home/Filings/4/0001104659-18-048859
4//SEC Filing

LITTLECHILD JOHN W 4

Accession 0001104659-18-048859

CIK 0001509745other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 7:21 PM ET

Size

5.7 KB

Accession

0001104659-18-048859

Insider Transaction Report

Form 4
Period: 2018-07-30
LITTLECHILD JOHN W
Director10% Owner
Transactions
  • Other

    Warrant (Right to Buy)

    2018-07-30+2,1372,137 total
    Exercise: $6.08From: 2017-11-14Exp: 2024-11-14Common Stock (2,137 underlying)
Footnotes (1)
  • [F1]Pro rata distribution from HealthCare Ventures IX, L.P., of which the reporting person is a limited partner. The reporting person is also a Managing Director of HealthCare Partners VIII, LLC, which is General Partner of HealthCare Partners VIII, L.P., which is the General Partner of HealthCare Ventures VIII, L.P. ("HCV VIII"). HCV VIII continues to hold 2,618,406 shares of common stock, representing 17.8% of the outstanding shares of common stock.

Documents

1 file

Issuer

LEAP THERAPEUTICS, INC.

CIK 0001509745

Entity typeother

Related Parties

1
  • filerCIK 0001013469

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 7:21 PM ET
Size
5.7 KB